Article info
PDFResearch ethics
Electronic pages
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception
- Professor I Durand-Zaleski, AP-HP, Henri Mondor hospital, Public Health, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France; isabelle.durand-zaleski{at}hmn.aphp.fr
Citation
Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception
Publication history
- Received October 24, 2007
- Revised March 14, 2008
- Accepted April 3, 2008
- First published August 29, 2008.
Online issue publication
August 29, 2008
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group Ltd and the Institute of Medical Ethics
Other content recommended for you
- Influence of the law on risk and informed consent
- Two concepts of therapeutic optimism
- Are patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?
- Therapeutic appropriation: a new concept in the ethics of clinical research
- Are positive experiences of children in non-therapeutic research justifiable research benefits?
- Beyond informed consent: the therapeutic misconception and trust
- Clinical research on COVID-19: perceptions and barriers to participation in The Gambia
- Unconscious emotional reasoning and the therapeutic misconception
- Phase 1 oncology trials and informed consent
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis